← Back to Influence Map
Entity DossierOrganization
SANOFI US SERVICES INC
DC · US
pharmaceuticals
Tracked direct giving
$0
LDA reported lobbying spend
$12,455,000
Connections
10
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
HCRHealth Issues
$21.5MMMMMedicare/Medicaid
$21.4MTAXTaxation/Internal Revenue Code
$21.4MTRDTrade
$21.0MCPTCopyright/Patent/Trademark
$21.0MMANManufacturing
$20.7MTORTOR
$1.9MMEDMedical/Disease Research
$450KBUDBudget/Appropriations
$300KLobbying Firms Retained
In-house lobbyists (filed as its own registrant)$11.5M
CHECKMATE GOVERNMENT RELATIONS$450K
CROSSROADS STRATEGIES, LLC$350K
THORN RUN PARTNERS$350K
Bills Referenced in Lobbying Filings
insulinmarch-inPBM
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Commented on | Centers for Medicare & Medicaid Services | Public comment on CMS-2024-0157: Medicare Program: Alternative Payment Model Updates and the Increasing Organ Transplant Access Model | Source |
| Retained | MARSHALL & POPP, LLC | Hired MARSHALL & POPP, LLC to lobby on Pharmaceuticals | Source |
| Retained | CROSSROADS STRATEGIES, LLC | Hired CROSSROADS STRATEGIES, LLC to lobby on NIH March-In Rights | Source |
| Retained | THORN RUN PARTNERS | Hired THORN RUN PARTNERS to lobby on Pharmaceuticals | Source |
| Lobbied on | Pharmacy Benefit Manager Reform Act | LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $1,860,000 | Source |
| Lobbied on | Insulin Price Caps - State-Level Legislation | LDA filing: lobbied on Insulin Price Caps, period 1st Quarter (Jan 1 - Mar 31), reported amount $2,540,000 | Source |
| Lobbied on | MARCH-IN Rights Proposal (NIH Framework) | LDA filing: lobbied on NIH March-In Rights, period 1st Quarter (Jan 1 - Mar 31), reported amount $2,160,000 | Source |
| Lobbied on | Sugar Reform Act (S.832, 118th Congress) | LDA filing: lobbied on Sugar Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $2,540,000 | Source |
| Retained | CHECKMATE GOVERNMENT RELATIONS | Hired CHECKMATE GOVERNMENT RELATIONS to lobby on Pharmaceuticals | Source |
| Parent of | SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION) | Genzyme is a subsidiary of Sanofi, acquired in 2011 | Source |